Uma equipe de pesquisadores israelenses desenvolveu um teste sanguíneo simples para detectar a diabete gestacional. Liderados pelo professor Moshe Hod, da Petah Tikva’s Rabin Medical Center, os pesquisadores propuseram alternativas simples para o teste oral padrão de tolerância à glicose, que normalmente é feito entre a 24ª e a 28ª semana de gravidez e que implica na ingestão de doses de glicose para, em seguida, testar os níveis de açúcar no sangue.
Eles dizem que, por meio de um teste simples de glicose no sangue, sem a ingestão prévia de glicose por via oral, ou pela medição do peso e do tamanho do feto, é possível aumentar em 50% o número de casos de diabete gestacional diagnosticados no curso da gravidez. A diabetes gestacional provoca complicações como hipertensão ou a geração de um feto excepcionalmente grande, o que aumenta as chances de obesidade infantil.
Mais informações na notícia original, abaixo:
Simple blood test can diagnose gestational diabetes, Israeli team finds
Researchers say new ways could increase by up to 50 percent the number of cases of gestational diabetes that are diagnosed in the course of pregnancy.
By Dan Even
Haaretz
An Israeli research team has come up with what it says are simpler and more accurate ways to screen pregnant women for gestational diabetes, a condition with profound implications for the health of both mothers and their unborn and newborn infants.
The researchers, led by Prof. Moshe Hod of Petah Tikva's Rabin Medical Center, proposed simple alternatives to the standard oral glucose tolerance test, which is usually administered between the 24th and 28th week of pregnancy.
They said using either a simple blood-glucose test, without prior oral glucose ingestion, or measuring the size and weight of the fetus, could increase by up to 50 percent the number of cases of gestational diabetes that are diagnosed in the course of pregnancy.
Gestational diabetes often causes complications such as pregnancy-induced hypertension or an exceptionally big fetus, which increases the chances of child obesity. Every year 10,000 Israeli women - accounting for six percent of all pregnancies - are diagnosed with the disease. That rate is low for Western countries.
"Israeli pregnant women are younger and thinner," said Dr. Ofra Kalter-Leibovici, director of the Unit of Cardiovascular Epidemiology at Gertner Institute for Epidemiology & Health Policy and a member of the research team. "Therefore they are less prone to suffer from gestational diabetes."
The team's recommendations differ from those of a landmark study that was published in 2008 in the New England Journal of Medicine. The study, carried out by the International Association of the Diabetes and Pregnancy Study Groups, found that the current glucose tolerance tests fall far short of reflecting the real number of women suffering from diabetes during pregnancy.
It recommended using a single-dose, two-hour glucose tolerance test instead of the variant that can include successive ingestion of glucose and multiple blood tests. This recommendation was adopted by the American Diabetes Association.
Recent studies have shown that mild gestational diabetes can be treated through diet and exercise, with only 10 percent of cases requiring medical intervention.
"General practitioners can diagnose gestational diabetes in most cases," Kalter-Leibovici said. "These cases should not be treated by obstetricians specializing in high-risk pregnancies, who are unable to see all of these patients."
The findings of the study led by Hod were recently presented at a conference of the Israel National Institute for Health Policy Research.
"We are not adopting the recommendations automatically," Hod said. "We examine them according to the findings of Israeli and international studies, and measure potential financial costs. In any event, the findings prove that the modes of diagnosis of gestational diabetes need to change."
A panel will be set up to devise concrete recommendations that will in turn be submitted to respective panels of gynecologists and diabetes specialists for approval. At a later stage they will require the stamp of the the Health Ministry and the country's health maintenance organizations.
Another team, this one composed of both Israeli and American physicians, is in the process of developing a mathematical model that would assess the overall cost of the suggested alternatives to glucose tolerance tests.
Portal Podcultura
Pauta
Carla Manga
Colaborador de pautas
Camila Dias
Editor Chefe
Sandra Camillo
http://www.podcultura.com.br/
@podcultura
Nenhum comentário:
Postar um comentário